Searched for
EU GMP
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 crSpecialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with a...- Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
- Orchid Pharma shares in focus as U.S. FDA completes facility inspectionOrchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosp...
- Venus Remedies secures EU GMP renewal certificationVenus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem, and Oncology...
- Indoco Remedies gets EU-GMP certification for Himachal plantIndoco Remedies on Friday said it has received the EU GMP certification for its manufacturing site located in Himachal Pradesh. The company...
- Biocon Biologics gets EU GMP certification from Ireland's HPRAThe company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certif...
- IICT ties up with Nosch Labs for transfer of process knowhow to make anti-Covid drug 2-DGA press release here on Monday said as per the pact signed on June 11, Nosch Labs would commence manufacture of 2-DG drug after obtaining r...
- Strides Pharma Science's Puducherry facility successfully completes EU GMP inspectionThe inspection was carried out on April 28, 2021 and the company has now received the renewed GMP (Good Manufacturing Practices) certificat...
- Biocon's Malaysian arm gets EU GMP certification for insulin manufacturing facilityThe integrated insulins facility in Malaysia manufactures drug substance and drug products in vials, cartridges, and insulin delivery devic...
- Lupin Pharma gets Good Manufacturing Certificate for its biologic plantBiosimilar Etanercept is used to fight a range of severe auto-immune disorders.
- Dr Reddy's cracks 6% as German regulator issues six major observationsThe stock cracked 6.96 per cent to hit a low of Rs 2,069.10 on BSE.
- German regulator issues six major observations to Dr Reddy’s Duvvada facility“The auditor has cautioned that the facility will receive EU-GMP certification from the regulator up to November 2018 only when the regulat...
- German ban on Ranbaxy's Dewas product expands to entire EUAdding to Ranbaxy's regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member coun...
- Ranbaxy gains over 2% as EU lifts export ban on Toansa unitThe European drug regulator has said that drugs from the Ranbaxy’s Toansa unit are fine. The regulator also said that the corrective measur...
- EU lifts drug export ban from Ranbaxy's Toansa plantThe assessment of the Toansa facility by EMA followed an inspection by the USFDA, which revealed areas of non-compliance with GMP at the si...
- EU, UK evaluating FDA findings on Ranbaxy's Toansa facilityDays after US FDA banned import of Ranbaxy products to America from its Toansa plant, health regulators of EU & UK have said they are evalu...
- Drug companies need to follow EU standards from July 2The govt issued new guidelines that require India's drugs companies to comply with the Good Manufacturing Practice standards of the EU .
- India issues new guidelines for API exports to European UnionWith an aim to boost pharmaceutical exports, the govt said it has issued new guidelines to comply with the EU Good Manufacturing Practice s...
- Venus Remedies gets GMP accreditation from SudanPharmaceutical company Venus Remedies on Tuesday said that seven units at its Baddi plant in Himachal Pradesh have received the Good Manufa...
- Venus Remedies up 5% on GMP certificationHeavy buying in Venus Remedies shares continued for the second straight day Wednesday on receiving the European GMP certification for its C...
Load More
